23876-18-8

Usage

Uses

Used in Scientific Research:
2-(2-Methyl-6-nitrophenyl)acetic acid is used as a research chemical for [application reason], contributing to the advancement of chemical and pharmaceutical studies. Its unique structure and properties make it a valuable compound for investigating various chemical reactions and processes.
Used in Laboratory Applications:
2-(2-Methyl-6-nitrophenyl)acetic acid is used as a laboratory reagent for [application reason], facilitating the execution of various experimental procedures and analyses. Its distinctive chemical properties allow for its use in a wide array of laboratory settings, enhancing the accuracy and efficiency of scientific investigations.
Used in Pharmaceutical Development:
2-(2-Methyl-6-nitrophenyl)acetic acid is used as a pharmaceutical intermediate for [application reason], playing a crucial role in the synthesis of various drugs and medications. Its presence in the development process can lead to the creation of novel therapeutic agents with potential applications in the treatment of various medical conditions.
Used in Chemical Synthesis:
2-(2-Methyl-6-nitrophenyl)acetic acid is used as a synthetic building block for [application reason], enabling the construction of more complex molecules with diverse applications. Its unique structure and reactivity make it an essential component in the synthesis of a wide range of chemical compounds, from dyes to polymers.

Upstream product

• 83-41-0 2,3-dimethylnitrobenzene 
• 95-92-1 oxalic acid diethyl ester 
• 917-58-8 potassium ethoxide 
• 70467-01-5 (2-methyl-6-nitro-phenyl)-pyruvic acid 

Downstream Products

• 23914-04-7 2-Methyl-6-nitro-phenylessigsaeure-methylester 
• 119209-29-9 4-(6-Methyl-2-nitrophenyl)acetessigsaeure-ethylester 
• 119209-35-7 (1'E,2Z)-3-Amino-2-(2-formylethenyl)-4-(6-methyl-2-nitrophenyl)crotonsaeure-ethylester 
• 119209-38-0 2-(6-Methyl-2-nitrobenzyl)nicotinsaeure-ethylester 
• 119209-32-4 (Z)-3-Amino-4-(6-methyl-2-nitrophenyl)crotonsaeure-ethylester 

Relevant academic research and scientific papers

Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors

The present invention is directed to a class indolinone compounds, hexahydro-cyclohepta-pyrrole oxindoles, which are useful as protein kinase inhibitors.

Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives

The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.

Combination therapy for the treatment of cancer

The present invention relates to methods for treatment or prevention of neoplasia disorders using protein tyrosine kinase inhibitors in combination with cyclooxygenase inhibitors, in particular cyclooxygenase-2 selective inhibitors.

Pyrrole substituted 2-indolinone protein kinase inhibitors

The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.

3-heteroarylidene-2-indolinone protein kinase inhibitors

The present invention relates to novel 3-heteroarylidene-2-indolinone compounds and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.

3-(cycloalkanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors

The present invention relates to novel 3-(cycloalkano-heteroarylidenyl)-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which are expected to modulate the activity of protein tyrosine kinases and therefore to be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer.

3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors

The present invention relates to novel 3-(cycloalkanoheteroarylidenyl)-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which are expected to modulate the activity of protein tyrosine kinases and therefore to be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer.